Journal article · 2025 · Open access
Optimizing resazurin-based viability assays for P-MSC/TER308 cell line to enhance results reliability
BMC Research Notes, 18(1), 228 · Published 22 May 2025 · DOI 10.1186/s13104-025-07298-w
In brief
“Optimizing resazurin-based viability assays for P-MSC/TER308 cell line to enhance results reliability” is a 2025 journal article by Jessica Petiti and 2 co-authors, published in BMC Research Notes. OpenAlex counts 4 citations as of 15 November 2026, which puts it in the top 9% of works published in 2025 by citations. It is open access under a CC BY-NC-ND licence: the full text is free to read at BMC Research Notes.
- Citations
- 4
- Most cited in
- 2025 (2)
- Field-weighted impact
- 3.33
- References
- 15
- Authors
- 3
Abstract
OBJECTIVE: The results of this research contribute to the LifeSaver project, which focuses on reducing neonatal and infant mortality resulting from preterm births. The project aims to create an in vitro system simulating prenatal conditions to screen and analyze chemicals and pharmaceuticals, establishing scientifically justified regulations for their use during pregnancy. Because several papers have recently identified data inconsistencies in pre-clinical studies, a key part of the project involves optimizing cellular cytotoxicity assays to enhance the reliability of pharmacological and toxicity screening for drugs and environmental contaminants. RESULTS: The resazurin-based viability assay was chosen as the primary method due to its widespread adoption and simplicity in assessing drug cytotoxicity. This work describes the optimization of the resazurin-based viability assay on the P-MSC/TERT308 cell line, a placenta-derived mesenchymal stem cell used within the LifeSaver project. By applying our previously described and validated Standard Operating Procedure, we fine-tuned experimental parameters, consistently obtaining reliable results with measurement uncertainty of less than 10%.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Petiti, J., Revel, L., & Divieto, C. (2025). Optimizing resazurin-based viability assays for P-MSC/TER308 cell line to enhance results reliability. BMC Research Notes, 18(1), 228. https://doi.org/10.1186/s13104-025-07298-w
MLA 9
Petiti, Jessica, et al. “Optimizing resazurin-based viability assays for P-MSC/TER308 cell line to enhance results reliability.” BMC Research Notes, vol. 18, no. 1, 2025, p. 228. https://doi.org/10.1186/s13104-025-07298-w.
Chicago
Petiti, Jessica, Laura Revel, and Carla Divieto. 2025. “Optimizing resazurin-based viability assays for P-MSC/TER308 cell line to enhance results reliability.” BMC Research Notes 18 (1): 228. https://doi.org/10.1186/s13104-025-07298-w.
Harvard
Petiti, J., Revel, L. and Divieto, C. (2025) ‘Optimizing resazurin-based viability assays for P-MSC/TER308 cell line to enhance results reliability’, BMC Research Notes, 18(1), p. 228. doi:10.1186/s13104-025-07298-w.
IEEE
J. Petiti, L. Revel, and C. Divieto, “Optimizing resazurin-based viability assays for P-MSC/TER308 cell line to enhance results reliability,” BMC Research Notes, vol. 18, no. 1, p. 228, 2025, doi: 10.1186/s13104-025-07298-w.
BibTeX
@article{petiti2025optimizing,
title = {{Optimizing resazurin-based viability assays for P-MSC/TER308 cell line to enhance results reliability}},
author = {Petiti, Jessica and Revel, Laura and Divieto, Carla},
journal = {BMC Research Notes},
year = {2025},
volume = {18},
number = {1},
pages = {228},
doi = {10.1186/s13104-025-07298-w},
url = {https://doi.org/10.1186/s13104-025-07298-w}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- placenta-derived mesenchymal stem cells
- cytotoxicity screening
- assay optimization
- measurement uncertainty
- preterm birth
- environmental pollutants
Work with this paper
Most-cited papers in Veterinary
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysTim R. Mosmann · Journal of Immunological Methods · 1983 · 57,115 citations
- Guide for the Care and Use of Laboratory Animals: Eighth EditionNational Research Council · National Academies Press eBooks · 2011 · 16,572 citations
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningPhilip Skehan, Ritsa Storeng, Dominic A. Scudiero and 7 more · JNCI Journal of the National Cancer Institute · 1990 · 9,860 citations
- Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal ResearchCarol Kilkenny, William J. Browne, Innes C. Cuthill and 2 more · PLoS Biology · 2010 · 7,617 citations
- The ARRIVE guidelines 2.0: Updated guidelines for reporting animal researchNathalie Percie du Sert, Viki Hurst, Amrita Ahluwalia and 25 more · PLoS Biology · 2020 · 6,761 citations
Questions about this paper
How do I cite this paper in APA style?
Petiti, J., Revel, L., & Divieto, C. (2025). Optimizing resazurin-based viability assays for P-MSC/TER308 cell line to enhance results reliability. BMC Research Notes, 18(1), 228. https://doi.org/10.1186/s13104-025-07298-w
How many times has this paper been cited?
4 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access: read the free full text at BMC Research Notes.
Who wrote this paper?
Jessica Petiti, Laura Revel, Carla Divieto.
What is the DOI of this paper?
10.1186/s13104-025-07298-w. The permanent link is https://doi.org/10.1186/s13104-025-07298-w.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.